Lindonlight Collective

🎉 Happy New Year from Lindonlight Collective! 🎉 As we welcome 2025, we’re filled with hope, determination, and excitement for what lies ahead. This past year has been one of incredible progress, made possible by our dedicated team, brilliant collaborators, and supportive community. Here’s to a year of innovation, collaboration, and breakthroughs. Thank you for being part of this journey! 💙 Cheers to 2025! #HappyNewYear #LindonlightCollective #Hope #Innovation

✨ Reflecting on Progress, Empowering the Future ✨ As the year comes to a close, we at Lindonlight Collective are reflecting on the strides made toward advancing research for pediatric brain cancer. From forging new collaborations to funding groundbreaking projects, every step has brought us closer to our shared goal of a brighter future for children and families. We're deeply grateful for our partners, researchers, and supporters who fuel this journey with unwavering dedication. Together, we’re not just advancing science; we’re changing lives. #LindonlightCollective #PediatricCancerResearch #Celebrating2024

Happy Holidays from Lindonlight Collective! May this holiday season bring joy, warmth, and moments of reflection for all. We look forward to continuing our mission in the new year, fueled by hope and determination.

As the year draws to a close, we want to take a moment to express our heartfelt gratitude to the incredible team at Lindonlight Collective. 💙 Your passion, dedication, and unwavering commitment to advancing pediatric brain cancer research inspire us every day. From groundbreaking ideas to the day-to-day work that fuels our mission, every effort you make brings us closer to transforming the lives of children and families. Here’s to the amazing progress we’ve made together in 2024 and to all the incredible achievements yet to come in 2025. We’re so proud to have such talented and driven individuals as part of our journey. Thank you for making Lindonlight Collective a force for hope, innovation, and change. 🌟 #TeamLindonlight #Thankful #PediatricBrainCancerResearch #Innovation #LindonlightCollective

🌟 Advancing Pediatric Brain Cancer Research 🌟 We are proud to announce that Lindonlight Collective has awarded $1.97 million to Dr. Petra Hamerlik at the The University of Manchester for her pioneering work on pediatric low-grade gliomas. 🧬 About the Project: Dr. Hamerlik’s research will develop 3D spheroid cultures and patient-derived models to enable more accurate preclinical drug testing and aid in biomarker discovery. This critical work bridges a major gap in pediatric brain cancer research and brings us closer to improved treatments for children. #PediatricCancerResearch #BrainCancer #PreclinicalModels #ResearchFunding #LindonlightCollective #InnovationInScience #Gliomas

Daiichi Sankyo is deeply saddened by the passing of Dr. Toshinori Agatsuma, Executive Officer, Head of Research, Daiichi Sankyo, who passed away on December 5, 2024. A true scientific innovator in every sense of the word, Dr. Agatsuma leaves an immeasurable legacy on the global oncology community as a pioneer of hope for countless people impacted by cancer. His patience, scientific expertise and compassionate leadership altered the trajectory of Daiichi Sankyo into a company with competitive advantage in oncology.     We invite you to learn more about the life and legacy Dr. Agatsuma and the profound impact he had on patients around the world. Company website statement: https://bit.ly/3ZrhDN0 Pursuing Anticancer Drug Possibilities: https://bit.ly/3ZFVo7e  Dr. Agatsuma’s Story: https://bit.ly/4ghBODO   Q&A on Japan Bioindustry Award: https://bit.ly/4fWJ4FB     Dr. Agatsuma's pursuit to transform science into medicine has helped make the world a better place and will benefit the patients of today, tomorrow and beyond. We send our deepest condolences to his family. 

We’re incredibly proud to support Editpep in closing their Seed round with an $8.4 million investment. Their groundbreaking work brings us closer to finding cures for pediatric brain cancer and other central nervous system diseases. Huge congratulations to the Editpep team – we’re excited to see where this journey takes you, and we’re honored to be part of it. #LindonlightCollective #ImpactInvesting #PediatricBrainCancer #InnovativeTherapeutics #HealthcareInnovation #Editpep

Celebrating Nobel Prize Day: Honoring Pioneers in Science and Discovery At Lindonlight Collective, we are constantly inspired by the transformative discoveries recognized by The Nobel Prize. These groundbreaking achievements remind us of the incredible impact research and innovation can have on the world. As we work to fund cutting-edge research in pediatric brain cancer, we aim to follow in the footsteps of these visionaries—supporting advancements that save lives and expand our understanding of science. Today, we honor not only the Nobel laureates but also every researcher, scientist, and innovator committed to making a difference. Together, we continue to push boundaries and bring hope to patients and their families. 🔬✨ Let’s keep championing the spirit of discovery! #NobelPrizeDay #ResearchMatters #PediatricCancerResearch #LindonlightCollective

🎉 Exciting news from Lindonlight Collective! We are honored to present a $280,000 Research Enabling Infrastructure Award to Dr. Xiao-Nan Li at the Ann & Robert H. Lurie Children's Hospital of Chicago. This award will support the Infrastructure Creation of Pediatric Glioma Models, advancing critical resources for research in pediatric brain cancer. At Lindonlight, we are committed to not only funding high-risk, high-reward scientific projects and clinical trials but also building the foundational infrastructure necessary for transformative breakthroughs. 📸 Pictured: Dr. Li and his laboratory accepting the award—a significant step forward in our shared mission to accelerate progress in pediatric glioma research. A heartfelt thank you to our supporters and the entire Lindonlight team for helping make this possible. Together, we are driving impactful change! #LindonlightCollective #PediatricBrainCancer #ResearchInnovation #PediatricGlioma #ScientificInfrastructure

Please join me in welcoming Ashvin Jaiswal, Ph.D. to Lindonlight Collective as our new Principal specializing in Immunotherapy! Dr. Jaiswal brings over a decade of experience in oncology and immuno-oncology, with a focus on biomarker strategies and translational research. His expertise will be instrumental as we continue our mission to advance therapies for pediatric brain cancer. Welcome to the team, Ashvin! #Welcome #TeamLindonlight #PediatricBrainCancer #LindonlightCollective